Does a Laparoscopic Approach to Distal Pancreatectomy for Cancer Contribute to Optimal Adjuvant Chemotherapy Utilization?

• Chemotherapy after pancreatic cancer surgery can significantly improve survival, but many patients who undergo open surgery recover too slowly to start on time. This study examined whether laparoscopic surgery helps more patients receive their full course of chemotherapy.
• Laparoscopic pancreas surgery offers smaller incisions, less blood loss, shorter hospital stays, and faster recovery, which matters because faster recovery means sooner chemotherapy.
• Pancreatic cancer remains challenging to treat; this study addresses whether surgical technique influences a patient's ability to complete their full treatment plan.
• Dr. de la Cruz-Muñoz's involvement reflects expertise in advanced laparoscopic surgery beyond weight loss procedures, sought by cancer surgery specialists.
• Published in Annals of Surgical Oncology, one of the most respected journals in its field.
• This is part of a two-paper series demonstrating contributions to advanced laparoscopic surgical oncology.

Why This Study Was Needed

For pancreatic cancer in the body or tail of the pancreas, surgeons remove that portion of the gland in an operation called distal pancreatectomy. Chemotherapy after surgery improves survival, but patients who recover slowly may start it late or not at all. Laparoscopic surgery speeds recovery, yet it was unclear whether that translates into better cancer care, or whether the laparoscopic approach removes the tumor as completely as open surgery.

How the Study Was Done

The team analyzed the National Cancer Database from 2010 to 2016, identifying 3,411 patients who had distal pancreatectomy for pancreatic adenocarcinoma: 996 laparoscopic and 2,415 open. They compared margins, length of stay, mortality, readmissions, survival and the use and timing of chemotherapy, accounting for hospital volume.

What the Study Found

• Open surgery had higher odds of readmission and longer hospital stays.
• 30-day mortality, 90-day mortality and overall survival did not differ significantly between approaches.
• The highest-volume centers were more likely to deliver chemotherapy regardless of approach.
• At higher-volume centers, laparoscopic surgery was associated with fewer positive margins, greater chemotherapy use and fewer chemotherapy delays.

What This Means for Patients

In selected patients, laparoscopic pancreas surgery is oncologically safe, and in experienced, high-volume centers it may help patients complete their full cancer treatment. Where you have surgery and who performs it matters. Learn about complex tumor surgery and minimally invasive surgery.

Clinical Pearls

• Laparoscopic distal pancreatectomy is an oncologically safe alternative to open surgery in selected patients.
• Hospital volume independently improves the odds of receiving chemotherapy.
• Experienced teams achieve the best combination of margins and chemotherapy delivery.

Strengths and Limitations

The study uses a large national cancer registry. Patients were not randomized, and surgeons may have chosen laparoscopy for smaller or less complex tumors.

Expert Commentary

Minimally invasive surgery is not only about smaller scars. For cancer patients, a faster recovery can mean starting chemotherapy on time, and that can affect survival. Working with my surgical oncology colleagues on this study reinforced how much experience and volume matter.

— Dr. Nestor de la Cruz-Muñoz

Related Research

• Preoperative Prognosticators of Safe Laparoscopic Hepatocellular Carcinoma Resection in Advanced Cirrhosis: A Propensity Score Matching Population-Based Analysis of 1,799 Western Patients
• Laparoscopic Pancreatoduodenectomy After Laparoscopic Gastric Bypass